** Shares of J B Chemicals and Pharmaceuticals Ltd JBCH.NS
up as much as 13.2% to record high of 2,773.95 rupees
** Stock on track to rise for third straight session
** Kotak Institutional Equities and IIFL Securities identify
JBCH as one of the cos to lead India growth momentum in Q1FY24
** JBCH likely to continue outperforming industry growth in
Q1 led by robust growth in chronic therapies; to post 10%-12%
Y/Y organic growth in India business - IIFL Securities
** Despite short-term impact of delayed monsoons, domestic
pharma market growth resilient; expect India formulations
revenue to clock over 11% CAGR over FY23-26 - brokerages
** Over 737,000 shares change hands by 01:06 p.m. IST, 9.5x
the 30-day moving avg
** 12 analysts have a "buy" or "strong buy" rating, two rate
it "hold"; median PT is 2,387.50 rupees - Refinitiv data
** As of last close, stock up 26% this year
(Reporting by Kashish Tandon in Bengaluru)
((Kashish.tandon@thomsonreuters.com))